AB Science (EUR)
AB
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
Industry-
Day Range6.63 | 7.29
52-Wk Range |
Last Close6.94
Mkt Cap (m)295.11
Dividend yield-
ISINFR0010557264
Volume218,521
Exchange VenuePAR

Company Profile

AB Science is a pharmaceutical company. It is engaged in research, development, & commercialization of tyrosine kinase inhibitors, therapeutic drugs used in treating cancerous tumors, inflammatory & neuro-degenerative diseases in both humans & animals.

Key Information
Price/Earning-
Price/Book0.00
Price/Sales161.91
P/CF-
Rev Growth (3 year avg)-
EPS Growth (3 year avg)-
Operating Margin % -
Net Margin %-
Return on Equity-
Debt/Equity-

Documents

Financials

Income Statement
EUR201420152016201720182019
Revenue (m)22222-
Operating Income (m)-15-26-30-28-29-
Net Income (m)-16-27-28-27-26-
Basic EPS-0.49-0.78-0.78-0.75-0.69-
Avg. Diluted Shares Outstanding (m)3334363638-
Balance Sheet
EUR201420152016201720182019
Current Assets (m)3031364921-
Non Current Assets (m)22222-
Total Assets (m)3133385122-
Current Liabilities (m)1418201919-
Total Liabilities (m)------
Total Equity (m)-16-17-511-15-
Cash Flows
EUR201420152016201720182019
Operating Cash Flows (m)-14-23-34-23-27-
Capital Expenditure (m)-1-1-1-1-
Figures are quoted in EUR unless stated otherwise
-
No change
6.94
Last Price